Login Start free

Focus

Drug Discovery Investors: Angels and VC Firms

The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.

Strongest in New York, San Francisco and Boston

Common stages: Seed and Series A

4,683: Drug Discovery investors
239: Angel investors
4,444: People at VC/PE firms
1,313: Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

4,683 Drug Discovery investors

Showing 261-280

Filters

Viewing

Drug Discovery4,683

Investor Type

Choosing one replaces Drug Discovery.

Investment Stage

Choosing one replaces Drug Discovery.

Seed84,745
Series A53,997
Late-Stage37,937
Series B35,865
Growth34,738
Pre-Seed32,477

Investment Profile

Choosing one replaces Drug Discovery.

SaaS63,483
FinTech54,183
Healthcare53,462
Consumer46,735
AI46,189
Hardware36,507
Commerce32,773
Climate23,313
Real Estate17,905
Education13,608
Food10,848
Travel7,450
Energy946
Agriculture555

Country

Choosing one replaces Drug Discovery.

City

Choosing one replaces Drug Discovery.

Focus1

Investor	Location	Type	Markets	Contact	Actions
LaToya Wilson Managing Director at Morgan Stanley	New York, United States	Corporate VCPrivate equity	FinTechHardware		View profile
Sunny Reddy Principal at Aisling Capital	New York, United States	Venture capital	Healthcare		View profile
Jason Kelly Founder at Ginkgo Bioworks	Cambridge, United States	Corporate VC	AIClimate		View profile
Sachin Uppal Angel Investor at LVX	Bengaluru, India	Syndicate / Angel groupVenture capital	HealthcareSaaS		View profile
James K. Venture Investor at New Enterprise Associates (NEA)	San Francisco, United States	Venture capital	AICommerce		View profile
Martin Majlund Investor at American Chemical Society	Princeton, United States	Government-backed	ClimateEducation		View profile
Brooke Seawell Board of Directors / Audit Committee Chair at NVIDIA	Menlo Park, United States	Corporate VCVenture capital	AICommerce		View profile
Helga Mikkelsen Investment Manager at Brandon Capital	Perth, Australia	Venture capital	Healthcare		View profile
Sarah Hymowitz Partner at The Column Group	San Francisco, United States	Venture capital	Healthcare		View profile
Ron Bernal Venture Advisor at New Enterprise Associates (NEA)	Longmont, United States	Venture capital	AICommerce		View profile
Elizabeth Hamrick Executive Director at Morgan Stanley	New York, United States	Corporate VCPrivate equity	FinTechHardware		View profile
Jared Teo Managing Director at Healthquest Capital	San Francisco, United States	Private equityVenture capital	AIHealthcare		View profile
Ignacio Puig Masllorens General Partner at Inveready	Barcelona, Spain	Private equityVenture capital	AICommerce		View profile
Zara Asgharpour Investor at Lonza	Basel, Switzerland	Corporate VC	Healthcare		View profile
Pierre Paffenhoff Climate Tech Venture Capital - Investment Director at Fonds de solidarité FTQ	Montreal, Canada	Private equityVenture capital	AIClimate		View profile
Emil Willemoes Helms LD Fonde at Ld Pensions	Copenhagen, Denmark	Family Office	Healthcare		View profile
Falon Donohue Affiliated at Narya Capital	United States	Venture capital	FoodHealthcare		View profile
Christopher Gagliardi Principal at Sanofi	Boston, United States	Corporate VC	AIHealthcare		View profile
Francesc Dosrius Lleonart Associate Director at Sanofi	Spain	Corporate VC	AIHealthcare		View profile
Avi Kometz Partner at Deerfield Management	New York, United States	Private equityVenture capital	AIHealthcare		View profile

Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal